Literature DB >> 7193726

Mechanism of cis-platinum nephrotoxicity: II. Morphologic observations.

D C Dobyan, J Levi, C Jacobs, J Kosek, M W Weiner.   

Abstract

Light microscopy, transmission electron microscopy and scanning electron microscopy were used to characterize the morphologic alterations and to localize the site of injury within the kidney 1, 2, 3, 5 and 7 days after the intraperitoneal injection of cis-diamminedichloroplatinum. Pathologic alterations were evident 3 days after the injection of the drug and were localized to the S3 segment of the proximal tubule situated in the outer stripe of the outer medulla. A spectrum of changes was seen in this S3 segment which included a thinning or focal loss of brush border, cellular swelling, condensation of the nuclear chromatin and focal areas of necrosis. After 5 days, widespread tubular necrosis of the S3 segment in the outer stripe was the predominant finding. Necrotic tubular epithelial cells could be seen detaching from the basal lamina and being sloughed into the tubular lumen. Only a bare basal lamina remained in many areas. Regeneration of the S3 segment was seen after 7 days and was characterized by tubules with widely dilated lumens which were lined by many low-lying epithelial cells. The observation that cis-diamminedichloroplatinum exerts its nephrotoxic effect on the S3 segment of the proximal tubule located in the outer stripe of the outer medulla demonstrates that the pattern of injury produced by this antitumor drug is similar to that associated with other nephrotoxic and ischemic models of acute renal failure.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7193726

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  68 in total

1.  Effects of arbekacin and vancomycin on release of lactate dehydrogenase and fragmentation of DNA in LLC-PK1 kidney epithelial cells.

Authors:  T Nakamura; T Kokuryo; M Okuda; Y Hashimoto; K Inui
Journal:  Pharm Res       Date:  1999-07       Impact factor: 4.200

Review 2.  Cisplatin nephrotoxicity. A review.

Authors:  G Daugaard; U Abildgaard
Journal:  Cancer Chemother Pharmacol       Date:  1989       Impact factor: 3.333

3.  Acute cisplatin nephrotoxicity in the rat. Evidence for impaired entry of sodium into proximal tubule cells.

Authors:  M J Field; T E Bostrom; F Seow; A Z Györy; D J Cockayne
Journal:  Pflugers Arch       Date:  1989-09       Impact factor: 3.657

4.  The effects of cisplatin on the concentration of protein thiols and glutathione in the rat kidney.

Authors:  P Mistry; Y Merazga; D J Spargo; P A Riley; D C McBrien
Journal:  Cancer Chemother Pharmacol       Date:  1991       Impact factor: 3.333

5.  Mitochondrial Homeostasis in Acute Organ Failure.

Authors:  L Jay Stallons; Jason A Funk; Rick G Schnellmann
Journal:  Curr Pathobiol Rep       Date:  2013-09

6.  Loss of the Na+/H+ Exchange Regulatory Factor 1 Increases Susceptibility to Cisplatin-Induced Acute Kidney Injury.

Authors:  Adrienne Bushau-Sprinkle; Michelle Barati; Caryl Conklin; Tess Dupre; Kenneth B Gagnon; Syed J Khundmiri; Barbara Clark; Leah Siskind; Mark A Doll; Madhavi Rane; Michael Brier; Susan Coventry; Eleanor D Lederer
Journal:  Am J Pathol       Date:  2019-03-27       Impact factor: 4.307

7.  Potentiated nephrotoxicity of cisplatin when combined with amikacin comparing young and adult rats.

Authors:  H T Jongejan; A P Provoost; J C Molenaar
Journal:  Pediatr Nephrol       Date:  1989-07       Impact factor: 3.714

8.  Physiological model for the pharmacokinetics of cis-dichlorodiammineplatinum (II) (DDP) in the tumored rat.

Authors:  F F Farris; F G King; R L Dedrick; C L Litterst
Journal:  J Pharmacokinet Biopharm       Date:  1985-02

9.  Premedication with intravenous magnesium has a protective effect against cisplatin-induced nephrotoxicity.

Authors:  Yoshitaka Saito; Masaki Kobayashi; Takehiro Yamada; Kumiko Kasashi; Rio Honma; Satoshi Takeuchi; Yasushi Shimizu; Ichiro Kinoshita; Hirotoshi Dosaka-Akita; Ken Iseki
Journal:  Support Care Cancer       Date:  2016-10-03       Impact factor: 3.603

10.  Evidence for lack of mitochondrial DNA repair following cis-dichlorodiammineplatinum treatment.

Authors:  G Singh; E Maniccia-Bozzo
Journal:  Cancer Chemother Pharmacol       Date:  1990       Impact factor: 3.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.